Ptc Therapeutics (PTCT) Preferred Dividend Payments (2012 - 2013)
Ptc Therapeutics (PTCT) posted quarterly Preferred Dividend Payments of $18.2 million for Q1 2013, up 8567505.63% quarter-over-quarter from $213.0 in Q4 2012.
Ptc Therapeutics (PTCT) Preferred Dividend Payments (2012 - 2013) Analysis & Trends
Ptc Therapeutics' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $18.2 million for Q1 2013.
- In Q1 2013, Preferred Dividend Payments changed N/A year-over-year to $18.2 million; the TTM figure through Dec 2013 stood at $18.2 million (changed N/A YoY), while the FY2025 annual figure was $97.0 million, changed N/A from the prior year.
- Preferred Dividend Payments for Q1 2013 stood at $18.2 million, up from $213.0 in the prior quarter.
- The five-year high for Preferred Dividend Payments was $18.2 million in Q1 2013, with the low at $213.0 in Q4 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Ptc Therapeutics | 5.97 Bn | 3.75 Bn | 340.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 18.25 Mn |
| Dec 31, 2012 | 213.00 |
| Jun 30, 2012 | 377,787.00 |